LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B
Publication
, Conference
Fangusaro, J; Onar-Thomas, A; Poussaint, TY; Wu, S; Ligon, AH; Lindeman, N; Banerjee, A; Packer, RJ; Kilburn, LB; Goldman, S; Pollack, IF ...
Published in: Neuro-Oncology
April 23, 2019
Duke Scholars
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
April 23, 2019
Volume
21
Issue
Supplement_2
Start / End Page
ii98 / ii99
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Fangusaro, J., Onar-Thomas, A., Poussaint, T. Y., Wu, S., Ligon, A. H., Lindeman, N., … Dunkel, I. J. (2019). LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B. In Neuro-Oncology (Vol. 21, pp. ii98–ii99). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noz036.145
Fangusaro, Jason, Arzu Onar-Thomas, Tina Young Poussaint, Shengjie Wu, Azra H. Ligon, Neal Lindeman, Anu Banerjee, et al. “LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B.” In Neuro-Oncology, 21:ii98–99. Oxford University Press (OUP), 2019. https://doi.org/10.1093/neuonc/noz036.145.
Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, et al. LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B. In: Neuro-Oncology. Oxford University Press (OUP); 2019. p. ii98–9.
Fangusaro, Jason, et al. “LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B.” Neuro-Oncology, vol. 21, no. Supplement_2, Oxford University Press (OUP), 2019, pp. ii98–99. Crossref, doi:10.1093/neuonc/noz036.145.
Fangusaro J, Onar-Thomas A, Poussaint TY, Wu S, Ligon AH, Lindeman N, Banerjee A, Packer RJ, Kilburn LB, Goldman S, Pollack IF, Jakacki RI, Qaddoumi I, Fisher PG, Dhall G, Baxter P, Kreissman SG, Stewart CF, Jones DTW, Pfister SM, Vezina G, Stern JS, Panigrahy A, Jones BV, Patay Z, Tamrazi B, Jones JY, Haque SS, Enterline DS, Cha S, Fisher MJ, Doyle A, Smith M, Fouladi M, Dunkel IJ. LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B. Neuro-Oncology. Oxford University Press (OUP); 2019. p. ii98–ii99.
Published In
Neuro-Oncology
DOI
EISSN
1523-5866
ISSN
1522-8517
Publication Date
April 23, 2019
Volume
21
Issue
Supplement_2
Start / End Page
ii98 / ii99
Publisher
Oxford University Press (OUP)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences